Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Teruki, Takeda"'
Autor:
Hiroki Watanabe, Ko Yamamoto, Hiroki Shiomi, Takeshi Morimoto, Eri Kato, Yukiko Matsumura, Kenji Nakatsuma, Yasuaki Takeji, Hidenori Yaku, Erika Yamamoto, Yugo Yamashita, Yusuke Yoshikawa, Masayuki Fuki, Kyohei Yamaji, Natsuhiko Ehara, Hiroki Sakamoto, Kazuaki Imada, Takeshi Tada, Ryoji Taniguchi, Ryusuke Nishikawa, Tomohisa Tada, Takashi Uegaito, Tatsuya Ogawa, Miho Yamada, Teruki Takeda, Hiroshi Eizawa, Nobushige Tamura, Keiichi Tambara, Satoru Suwa, Manabu Shirotani, Toshihiro Tamura, Moriaki Inoko, Junichiro Nishizawa, Masahiro Natsuaki, Hiroshi Sakai, Takashi Yamamoto, Naoki Kanemitsu, Nobuhisa Ohno, Katsuhisa Ishii, Akira Marui, Hiroshi Tsuneyoshi, Yasuhiko Terai, Shogo Nakayama, Kazuhiro Yamazaki, Mamoru Takahashi, Takashi Tamura, Jiro Esaki, Shinji Miki, Tomoya Onodera, Hiroshi Mabuchi, Yutaka Furukawa, Masaru Tanaka, Tatsuhiko Komiya, Yoshiharu Soga, Michiya Hanyu, Kenji Ando, Kazushige Kadota, Kenji Minatoya, Yoshihisa Nakagawa, Takeshi Kimura, On behalf the CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators
Publikováno v:
PLoS ONE, Vol 17, Iss 9, p e0267906 (2022)
AimsThere is a scarcity of studies comparing percutaneous coronary intervention (PCI) using new-generation drug-eluting stents (DES) with coronary artery bypass grafting (CABG) in patients with multi-vessel coronary artery disease.Methods and results
Externí odkaz:
https://doaj.org/article/20a5e4e53473496293e6056b4cf027c8
Autor:
Yutaka Furukawa, Kenji Nakatsuma, Takeshi Morimoto, Hiroki Shiomi, Kenji Ando, Tsukasa Inada, Moriaki Inoko, Katsuhisa Ishii, Kenji Minatoya, Takeshi Kimura, Kyohei Yamaji, Kazushige Kadota, Takashi Yamamoto, Hidenori Yaku, Erika Yamamoto, Yusuke Yoshikawa, Yoshihisa Nakagawa, Yukihito Sato, Yasuaki Takeji, Ryoji Taniguchi, Yugo Yamashita, Yukiko Mutsumura-Nakano, Ko Yamamoto, Junichi Tazaki, Satoru Suwa, Teruki Takeda, Manabu Shirotani, Natsuhiko Ehara, Tomoya Onodera, Eiji Shinoda, Hiroki Sakamoto, Yoshiharu Soga, Tatsuhiko Komiya, Eri Toda Kato, Hirotoshi Watanabe, Masayuki Fuki, Toshihiro Tamura, Hiroki Watanabe
Publikováno v:
BMJ Open, Vol 11, Iss 3 (2021)
Objective To evaluate changes in demographics, clinical practices and long-term clinical outcomes of patients with ST segment-elevation myocardial infarction (STEMI) before and beyond 2010.Design Multicentre retrospective cohort study.Setting The Cor
Externí odkaz:
https://doaj.org/article/23dc85c1bf0c4d72bc5c68f7d95c3df2
Autor:
Teruki Takeda, Tomohiro Dohke, Yoshiki Ueno, Toshiki Mastui, Masanori Fujii, Tomoyuki Takayama, Kenichi Dochi, Akashi Miyamoto, Hiroshi Mabuchi, Atsuyuki Wada
Publikováno v:
Heart and Vessels. 38:96-105
No predictive clinical risk scores for net adverse clinical events (NACE) have been developed for patients with atrial fibrillation (AF) after percutaneous coronary intervention (PCI). We evaluated NACE to develop clinically applicable risk-stratific
Autor:
Hiroshi Sakai, Hiroshi Eizawa, Atsushi Iwakura, Masaru Tanaka, Mamoru Toyofuku, Kazushige Kadota, Teruki Takeda, Hiroshi Mabuchi, Junichi Tazaki, Nobushige Tamura, Michiya Hanyu, Keiichi Tambara, Tatsuhiko Komiya, Tomoya Onodera, Junichiro Nishizawa, Takashi Uegaito, Kazuhisa Ishii, Toshihiro Tamura, Takeshi Kimura, Hiroki Shiomi, Mitsuo Matsuda, Takeshi Tada, Shinji Miki, Tadaaki Koyama, Kazuhisa Kaneda, Yoshihisa Nakagawa, Yukihito Sato, Yoshiharu Soga, Tomohisa Tada, Takeshi Aoyama, Yutaka Furukawa, Fumio Yamazaki, Satoru Suwa, Ryuzo Nawada, Hirotoshi Watanabe, Kenji Ando, Kyohei Yamaji, Yusuke Yoshikawa, Mamoru Takahashi, Tatsuya Ogawa, Jiro Esaki, Miho Yamada, Natsuhiko Ehara, Takeshi Morimoto, Moriaki Inoko, Takashi Yamamoto, Hiroki Sakamoto, Ryoji Taniguchi, Takashi Tamura, Shogo Nakayama, Manabu Shirotani, Hiroshi Tsuneyoshi, Eiji Shinoda, Nobuhisa Ohno, Naoki Kanemitsu, Kenji Minatoya, Tsukasa Inada
Publikováno v:
The American Journal of Cardiology. 153:20-29
The treatment of coronary artery disease has substantially changed over the past two decades. However, it is unknown whether and how much these changes have contributed to the improvement of long-term outcomes after coronary revascularization. We ass
Autor:
Kazuaki Imada, Teruki Takeda, Nobuhisa Ohno, Hiroshi Mabuchi, Hiroshi Eizawa, Kenji Minatoya, Yusuke Yoshikawa, Katsuhisa Ishii, Manabu Shirotani, Hiroshi Tsuneyoshi, Yasuaki Takeji, Kenji Ando, Takeshi Tada, Miho Yamada, Ko Yamamoto, Ryusuke Nishikawa, Takeshi Kimura, Tatsuya Ogawa, Satoru Suwa, Jiro Esaki, Naoki Kanemitsu, Yutaka Furukawa, Shinji Miki, Takashi Tamura, Yoshiharu Soga, Shogo Nakayama, Takashi Yamamoto, Kyohei Yamaji, Natsuhiko Ehara, Moriaki Inoko, Mamoru Takahashi, Keiichi Tambara, Toshihiro Tamura, Nobushige Tamura, Ryoji Taniguchi, Tomohisa Tada, Kazushige Kadota, Tatsuhiko Komiya, Takashi Uegaito, Hiroshi Sakai, Takeshi Morimoto, Kazuhiro Yamazaki, Hiroki Shiomi, Yoshihisa Nakagawa, Cabg Registry Cohort Investigators, Yasuhiko Terai, Yukiko Matsumura-Nakano, Masahiro Natsuaki, Michiya Hanyu, Tomoya Onodera, Junichiro Nishizawa, Masaru Tanaka, Hiroki Sakamoto, Akira Marui
Publikováno v:
The American Journal of Cardiology. 145:25-36
There is a scarcity of data comparing long-term clinical outcomes between percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) in patients with three-vessel coronary artery disease (3VD) in the new-generation drug-eluti
Autor:
Tomoko Sakaguchi, Tomoyuki Murakami, Hiroshi Mabuchi, Teruki Takeda, Takeshi Kimura, Keiko Maeda, Takanari Fujita, Takeshi Morimoto, Masayuki Yamaji, Yasushi Tsujino
Publikováno v:
Circulation Reports
Background: Few studies have investigated the importance of glycemic control in patients with diabetes mellitus (DM) for reducing the incidence of late target lesion revascularization (TLR) after implantation of new-generation drug-eluting stents (DE
Autor:
Kohei Asada, Teruki Takeda, Yosuke Higo, Yuichi Sawayama, Noriaki Yagi, Megumi Fukuyama, Masayuki Yamaji, Hiroshi Sakai, Hiroshi Mabuchi, Takashi Yamamoto, Yoshihisa Nakagawa
Publikováno v:
Heart and vessels. 37(11)
Clinical evidence demonstrating the impact of statins for preventing late target lesion revascularization (TLR) after newer-generation drug-eluting stent implantation and differences in the effect of statins on late TLR according to pre-interventiona
Autor:
Yukihito Sato, Yutaka Furukawa, Hiroshi Eizawa, Teruki Takeda, Takeshi Aoyama, Mamoru Takahashi, Kazuhisa Kaneda, Ryuzo Nawada, Manabu Shirotani, Tomoya Onodera, Takenori Domei, Masahiro Natsuaki, Hiroki Sakamoto, Yoshihisa Nakagawa, Ryoji Taniguchi, Ko Yamamoto, Hiroki Shiomi, Mitsuo Matsuda, Takeshi Kimura, Hiroshi Mabuchi, Takeshi Morimoto, Takashi Uegaito, Kyohei Yamaji, Hiroshi Sakai, Kazushige Kadota, Cabg Registry Cohort-Investigators, Katsuhisa Ishii, Miho Yamada, Natsuhiko Ehara, Hirotoshi Watanabe, Masaru Tanaka, Mamoru Toyofuku, Moriaki Inoko, Takashi Tamura, Toshihiro Tamura, Tomohisa Tada, Satoru Suwa, Eiji Shinoda, Kenji Ando, Takashi Yamamoto, Takeshi Tada, Shinji Miki, Tsukasa Inada
Publikováno v:
Circulation journal : official journal of the Japanese Circulation Society. 86(5)
BACKGROUND Optimal intensity is unclear for P2Y12receptor blocker therapy after percutaneous coronary intervention (PCI) in real-world clinical practice.Methods and Results:From the CREDO-Kyoto Registry, the current study population consisted of 25,4
Autor:
Hirotoshi Watanabe, Takeshi Morimoto, Masahiro Natsuaki, Yutaka Furukawa, Yoshihisa Nakagawa, Kazushige Kadota, Kyohei Yamaji, Kenji Ando, Satoshi Shizuta, Hiroki Shiomi, Tomohisa Tada, Junichi Tazaki, Yoshihiro Kato, Mamoru Hayano, Mitsuru Abe, Takashi Tamura, Manabu Shirotani, Shinji Miki, Mitsuo Matsuda, Mamoru Takahashi, Katsuhisa Ishii, Masaru Tanaka, Takeshi Aoyama, Osamu Doi, Ryuichi Hattori, Masayuki Kato, Satoru Suwa, Akinori Takizawa, Yoshiki Takatsu, Eiji Shinoda, Hiroshi Eizawa, Teruki Takeda, Jong-Dae Lee, Moriaki Inoko, Hisao Ogawa, Shuichi Hamasaki, Minoru Horie, Ryuji Nohara, Hirofumi Kambara, Hisayoshi Fujiwara, Kazuaki Mitsudo, Masakiyo Nobuyoshi, Toru Kita, Adnan Kastrati, Takeshi Kimura, CREDO-Kyoto PCI/CABG registry cohort-2 investigators
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0124314 (2015)
Relation of antiplatelet therapy (APT) discontinuation with the risk of serious cardiovascular events has not been fully addressed yet. This study is aimed to evaluate the risk of ischemic event after APT discontinuation based on long-term APT status
Externí odkaz:
https://doaj.org/article/a4903c06090b49bf9bb794b376d25517
Autor:
Kyohei, Yamaji, Hiroki, Shiomi, Takeshi, Morimoto, Yukiko, Matsumura-Nakano, Natsuhiko, Ehara, Hiroki, Sakamoto, Yasuaki, Takeji, Yusuke, Yoshikawa, Ko, Yamamoto, Eri T, Kato, Kazuaki, Imada, Takeshi, Tada, Ryoji, Taniguchi, Ryusuke, Nishikawa, Tomohisa, Tada, Takashi, Uegaito, Tatsuya, Ogawa, Miho, Yamada, Teruki, Takeda, Hiroshi, Eizawa, Nobushige, Tamura, Keiichi, Tambara, Satoru, Suwa, Manabu, Shirotani, Toshihiro, Tamura, Moriaki, Inoko, Junichiro, Nishizawa, Masahiro, Natsuaki, Hiroshi, Sakai, Takashi, Yamamoto, Naoki, Kanemitsu, Nobuhisa, Ohno, Katsuhisa, Ishii, Akira, Marui, Hiroshi, Tsuneyoshi, Yasuhiko, Terai, Shogo, Nakayama, Kazuhiro, Yamazaki, Mamoru, Takahashi, Takashi, Tamura, Jiro, Esaki, Shinji, Miki, Tomoya, Onodera, Hiroshi, Mabuchi, Yutaka, Furukawa, Masaru, Tanaka, Tatsuhiko, Komiya, Yoshiharu, Soga, Michiya, Hanyu, Takenori, Domei, Kenji, Ando, Kazushige, Kadota, Kenji, Minatoya, Yoshihisa, Nakagawa, Takeshi, Kimura
Publikováno v:
JACC. Asia. 2(3)
Diabetes is a well-known risk factor for adverse outcomes after coronary revascularization.This study sought to determine high-risk subgroups in whom the excess risks of diabetes relative to nondiabetes are particularly prominent and thus may benefit